These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23867487)

  • 21. Toward Better-Quality Compounded Drugs - An Update from the FDA.
    Woodcock J; Dohm J
    N Engl J Med; 2017 Dec; 377(26):2509-2512. PubMed ID: 29281577
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningitis outbreak reveals gaps in US drug regulation.
    Alcorn T
    Lancet; 2012 Nov; 380(9853):1543-4. PubMed ID: 23130359
    [No Abstract]   [Full Text] [Related]  

  • 26. History of sterile compounding in U.S. hospitals: learning from the tragic lessons of the past.
    Myers CE
    Am J Health Syst Pharm; 2013 Aug; 70(16):1414-27. PubMed ID: 23903480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal infections associated with contaminated methylprednisolone injections.
    Smith RM; Schaefer MK; Kainer MA; Wise M; Finks J; Duwve J; Fontaine E; Chu A; Carothers B; Reilly A; Fiedler J; Wiese AD; Feaster C; Gibson L; Griese S; Purfield A; Cleveland AA; Benedict K; Harris JR; Brandt ME; Blau D; Jernigan J; Weber JT; Park BJ;
    N Engl J Med; 2013 Oct; 369(17):1598-609. PubMed ID: 23252499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The art, science, and practice of pharmacy compounding.
    McDonough RP; Allen LV; Wettergreen S
    J Am Pharm Assoc (2003); 2013; 53(1):8-12. PubMed ID: 23636149
    [No Abstract]   [Full Text] [Related]  

  • 30. Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013.
    Smith RM; Derado G; Wise M; Harris JR; Chiller T; Meltzer MI; Park BJ
    Emerg Infect Dis; 2015 Jun; 21(6):933-40. PubMed ID: 25989264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compounding changes. Litigation, legislation among fallout from outbreak.
    Lee J
    Mod Healthc; 2013 Sep; 43(39):32-3. PubMed ID: 24199304
    [No Abstract]   [Full Text] [Related]  

  • 33. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
    Sheyman AT; Cohen BZ; Friedman AH; Ackert JM
    JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Response, Outbreak Investigation, and Epidemiology of the Fungal Meningitis Epidemic in the United States: Systematic Review.
    Abbas KM; Dorratoltaj N; O'Dell ML; Bordwine P; Kerkering TM; Redican KJ
    Disaster Med Public Health Prep; 2016 Feb; 10(1):145-51. PubMed ID: 26681583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Battlefront. Michigan hospital at forefront in national fight against outbreak from tainted injections.
    McKinney M
    Mod Healthc; 2012 Nov; 42(47):6-7, 16, 1. PubMed ID: 23488176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Under scrutiny. More control of compounding pharmacies sought.
    Lee J
    Mod Healthc; 2012 Oct; 42(43):12-3. PubMed ID: 23163094
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014.
    McCotter OZ; Smith RM; Westercamp M; Kerkering TM; Malani AN; Latham R; Peglow SL; Mody RK; Pappas PG; Chiller TM
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(42):1200-1. PubMed ID: 26513534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.